WILLIAM PEACOCK to Double-Blind Method
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Double-Blind Method.
Connection Strength
0.509
-
Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double-blind, Placebo-controlled Study (ENERGIZE). Acad Emerg Med. 2020 06; 27(6):475-486.
Score: 0.121
-
The management of acute hypertension in patients with renal dysfunction: labetalol or nicardipine? Postgrad Med. 2014 Jul; 126(4):124-30.
Score: 0.081
-
A randomized study of the efficacy and safety of intravenous acetaminophen compared to oral acetaminophen for the treatment of fever. Acad Emerg Med. 2011 Apr; 18(4):360-6.
Score: 0.065
-
Observation unit treatment of heart failure with nesiritide: results from the proaction trial. J Emerg Med. 2005 Oct; 29(3):243-52.
Score: 0.044
-
Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure. Am J Emerg Med. 2005 May; 23(3):327-31.
Score: 0.043
-
Nesiritide in congestive heart failure associated with acute coronary syndromes: a pilot study of safety and efficacy. J Card Fail. 2004 Apr; 10(2):120-5.
Score: 0.040
-
High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source. Stroke. 2020 08; 51(8):2386-2394.
Score: 0.031
-
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial. J Stroke Cerebrovasc Dis. 2018 Jun; 27(6):1673-1682.
Score: 0.026
-
Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure. N Engl J Med. 2017 05 18; 376(20):1956-1964.
Score: 0.025
-
Acute detection of ST-elevation myocardial infarction missed on standard 12-Lead ECG with a novel 80-lead real-time digital body surface map: primary results from the multicenter OCCULT MI trial. Ann Emerg Med. 2009 Dec; 54(6):779-788.e1.
Score: 0.015
-
The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure. Nephrol Dial Transplant. 2004 Feb; 19(2):391-9.
Score: 0.010
-
A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes. Am Heart J. 2003 Dec; 146(6):993-8.
Score: 0.010